The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Open accessAbstract
The composite human microbiome of Western populations has probably changed over the past century, brought on by new environmental triggers that often have a negative impact on human health. Here we show that consumption of a diet high in saturated (milk-derived) fat, but not polyunsaturated (safflower oil) fat, changes the conditions for microbial assemblage and promotes the expansion of a low-abundance, sulphite-reducing pathobiont, Bilophila wadsworthia. This was associated with a pro-inflammatory T helper type 1 (T(H)1) immune response and increased incidence of colitis in genetically susceptible Il10(−/−), but not wild-type mice. These effects are mediated by milk-derived-fat-promoted taurine conjugation of hepatic bile acids, which increases the availability of organic sulphur used by sulphite-reducing microorganisms like B. wadsworthia. When mice were fed a low-fat diet supplemented with taurocholic acid, but not with glycocholic acid, for example, a bloom of B. wadsworthia and development of colitis were observed in Il10(−/−) mice. Together these data show that dietary fats, by promoting changes in host bile acid composition, can markedly alter conditions for gut microbial assemblage, resulting in dysbiosis that can perturb immune homeostasis. The data provide a plausible mechanistic basis by which Western-type diets high in certain saturated fats might increase the prevalence of complex immune-mediated diseases like inflammatory bowel disease in genetically susceptible hosts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bacteria with BSH activity have benefited from enhanced tolerance against bile and better survival in the gut environment (Begley et al., 2006;Devkota et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Devkota et al., 2012
Experimental — accuracy not yet measuredIn the citing paper
“In Il10−/− mice and mice without disruption of this gene, a diet high in saturated (milk-derived) fat (MF) promoted expansion of the immunogenic sulfite-reducing pathobiont Bilophila wadsworthia, a member of the Deltaproteobacteria.174”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [174]
In the citing paper
“Bilophila wadsworthia, a sulphite-reducing bacteria, has been associated with an increased incidence of colitis [52], and emerges under pathological conditions such as appendicitis and other intestinal inflammatory disorders [52].”
From Intestinal Microbiota Is Influenced by Gender and Body Mass Index (2016) · cites this paper as [52]
In the citing paper
“Consumption of milk fat has been shown to alter bile acid composition, promoting expansion of the sulphite-reducing pathobiont Bilophila wadsworthia and exacerbating colitis in IL10 knockout mice69.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [69]
In the citing paper
“B. wadsworthia increases gut inflammation in mice that lack in the anti-inflammatory cytokine interleukin (IL)-10.”
From Diet–microbiota interactions as moderators of human metabolism (2016) · cites this paper as [111]
In the citing paper
“Levels of the bacterium Bilophila wadsworthia increase when mice are fed a diet rich in milk fat or supplemented with the bile acid taurocholic acid111.”
From Diet–microbiota interactions as moderators of human metabolism (2016) · cites this paper as [111]
In the citing paper
“This is in line with the suggestion that SRB are linked to an inflammatory state of the gut 41, 42.”
From The composition of the gut microbiota shapes the colon mucus barrier (2015) · cites this paper as [42]
In the citing paper
“This pathobiont promotes Th1 type immune responses and increases susceptibility to colitis in IL10–/– mice.137”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [137]
In the citing paper
“The gut microbiota has been shown to differ between mice fed diets that are high or low in fat and between diets that contain equal amounts of fat but from different sources [10–13] (Fig. 1).”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [13]
In the citing paper
“Milk fat promoted taurine-conjugation of bile acids, which increases the availability of sulfur used by B. wadsworthia.”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [13]
In the citing paper
“The increased levels of B. wadsworthia were associated with a pro-inflammatory immune response and increased incidence of colitis in genetically susceptible mice.”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [13]
In the citing paper
“Devkota et al showed that a diet with milk fat, but not diets with lard or safflower oil, increased expansion of Bilophila wadsworthia in mice [13].”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [13]
In the citing paper
“This phyla has been shown to be intimately tied to a pro-inflammatory state.11,60,61”
From Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases (2015) · cites this paper as [11]
In the citing paper
“For example, high SFA intake has been shown to be associated with reduction in total bacterial abundance in humans (95) and in microbial diversity and richness (95,96), as well as an increase in proinflammatory bacteria (e.g., Bilophila wadsworthia) (96)(97)(98) in mice.”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [96]
In the citing paper
“animals fed with a diet rich in animal-derived saturated fats demonstrated a significant increase in Proteobacteria (Bilophila wadsworthia) abundance (Devkota et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Devkota et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity
Hildebrandt, M. A., Hoffmann, C., Sherrill–Mix, S. A., Keilbaugh, S. A., Hamady, M., Chen, Y., Knight, R., Ahima, R. S., Bushman, F., & Wu, G. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.042 · Cited by 1,576
Diet, gut microbiota and immune responses
Maslowski, K. M., & Mackay, C. R. (2011) · Nature Immunology · doi:10.1038/ni0111-5 · Cited by 1,261
Berg, D., Davidson, N. M., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,125
The human gut microbiome: ecology and recent evolutionary changes
Walter, J., & Ley, R. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102830 · Cited by 720
Wang, Y., Hoenig, J. D., Malin, K. J., Qamar, S., Petrof, E. O., Sun, J., Antonopoulos, D. A., Chang, E. B., & Claud, E. C. (2009) · The ISME Journal · doi:10.1038/ismej.2009.37 · Cited by 600
Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases
Loubinoux, J., Bronowicki, J., Pereira, I. A. C., Mougenel, J.-L., & Faou, A. L. (2002) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2002.tb00942.x · Cited by 404
Evidence That Hydrogen Sulfide Is a Genotoxic Agent
Attene‐Ramos, M. S., Wagner, E. D., Plewa, M. J., & Gaskins, H. R. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0126 · Cited by 367
Dussurget, O., Cabanes, D., Dehoux, P., Lecuit, M., Buchrieser, C., Glaser, P., & Cossart, P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03080.x · Cited by 356
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,001
Araújo, J. R., Tomas, J., Brenner, C., & Sansonetti, P. J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.019 · Cited by 271
Ketogenic Diet and Microbiota: Friends or Enemies?
Paoli, A., Mancin, L., Bianco, A., Thomas, E., Mota, J. F., & Piccini, F. (2019) · Genes · doi:10.3390/genes10070534 · Cited by 276
Dietary fat, bile acid metabolism and colorectal cancer
Ocvirk, S., & O’Keefe, S. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.003 · Cited by 266
Changes of the human gut microbiome induced by a fermented milk product
Veiga, P., Pons, N., Agrawal, A., Oozeer, R., Guyonnet, D., Brazeilles, R., Faurie, J., Vlieg, J. E. T. V. H., Houghton, L. A., Whorwell, P. J., et al. (2014) · Scientific Reports · doi:10.1038/srep06328 · Cited by 266
Hydrogen sulfide in physiology and diseases of the digestive tract
Singh, S., & Lin, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040866 · Cited by 260
Keubler, L. M., Büettner, M., Häger, C., & Bleich, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000468 · Cited by 260
Aging progression of human gut microbiota
Xu, C., Zhu, H., & Qiu, P. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1616-2 · Cited by 258
Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 263
Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
Usuda, H., Okamoto, T., & Wada, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147613 · Cited by 277
Rethinking healthy eating in light of the gut microbiome
Armet, A. M., Deehan, E. C., O’Sullivan, A. F., Mota, J. F., Field, C. J., Prado, C. M., Lucey, A. J., & Walter, J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.04.016 · Cited by 252
Implications of the Westernized Diet in the Onset and Progression of IBD
Rizzello, F., Spisni, E., Giovanardi, E., Imbesi, V., Salice, M., Alvisi, P., Valerii, M. C., & Gionchetti, P. (2019) · Nutrients · doi:10.3390/nu11051033 · Cited by 258
Linking the Microbiota, Chronic Disease, and the Immune System
Hand, T. W., Vujkovic-Cvijin, I., Ridaura, V. K., & Belkaid, Y. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.08.003 · Cited by 247
Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice
Bian, X., Chi, L., Gao, B., Tu, P., Ru, H., & Lu, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00487 · Cited by 258
The microbiota in inflammatory bowel disease
Sheehan, D., Moran, C. P., & Shanahan, F. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1064-1 · Cited by 260
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis
Alenghat, T., Osborne, L. C., Saenz, S. A., Kobuley, D. E., Ziegler, C. G. K., Mullican, S. E., Choi, I., Grunberg, S., Sinha, R., Wynosky-Dolfi, M. A., et al. (2013) · Nature · doi:10.1038/nature12687 · Cited by 255
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Gut microbiota and non-alcoholic fatty liver disease: new insights
Aron‐Wisnewsky, J., Gaborit, B., Dutour, A., & Clément, K. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12140 · Cited by 257
Inflammatory Bowel Diseases and Gut Microbiota
Haneishi, Y., Furuya, Y., Hasegawa, M., Picarelli, A., Rossi, M., & Miyamoto, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043817 · Cited by 263
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Campbell, C., Kandalgaonkar, M. R., Golonka, R. M., Yeoh, B. S., Vijay–Kumar, M., & Saha, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020294 · Cited by 270
Hersoug, L., Möller, P., & Loft, S. H. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422417000269 · Cited by 253
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242
Microbiota Metabolites in Health and Disease
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K., & Ayres, J. S. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-071219-125715 · Cited by 255
Joyce, S. A., & Gahan, C. G. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033159 · Cited by 241
Cândido, F. G., Valente, F. X., Grześkowiak, Ł., Moreira, A. P. B., Rocha, D. M. U. P., & Alfenas, R. D. C. G. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1343286 · Cited by 248
Zeißig, S., & Blumberg, R. S. (2014) · Nature Immunology · doi:10.1038/ni.2847 · Cited by 243
Obesity and cancer pathogenesis
Berger, N. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12416 · Cited by 241
The microbiota in inflammatory bowel disease: Current and therapeutic insights
Lane, E. R., Zisman, T., & Suskind, D. (2017) · Journal of Inflammation Research · doi:10.2147/jir.s116088 · Cited by 226
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
Abegunde, A. T., Muhammad, B. H., Bhatti, O. I., & Ali, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6296 · Cited by 250
Baldini, F., Hertel, J., Sandt, E., Thinnes, C. C., Neuberger-Castillo, L., Pavelka, L., Betsou, F., Krüger, R., Thiele, I., Aguayo, G., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-00775-7 · Cited by 229
Vindigni, S. M., Zisman, T. L., Suskind, D. L., & Damman, C. J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644242 · Cited by 241
Gut Microbiota Metabolism and Interaction with Food Components
Vernocchi, P., CHIERICO, F. D., & Putignani, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103688 · Cited by 242
Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology
Molinero, N., Ruíz, L., Sánchez, B., Margollés, A., & Delgado, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00185 · Cited by 233
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., & Wu, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.634780 · Cited by 237
Role of the enteric microbiota in intestinal homeostasis and inflammation
Koboziev, I., Webb, C. R., Furr, K. L., & Grisham, M. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.008 · Cited by 235
Leveraging diet to engineer the gut microbiome
Wolter, M., Grant, E. T., Boudaud, M., Steimle, A., Pereira, G. V., Martens, E. C., & Desai, M. S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00512-7 · Cited by 211
Lam, Y. Y., Ha, C. W. Y., Hoffmann, J. M. A., Oscarsson, J., Dinudom, A., Mather, T. J., Cook, D. I., Hunt, N. H., Caterson, I. D., Holmes, A. J., et al. (2015) · Obesity · doi:10.1002/oby.21122 · Cited by 223
The role of diet in shaping human gut microbiota
Rinninella, E., Tohumcu, E., Raoul, P. C., Fiorani, M., Cintoni, M., Mele, M. C., Cammarota, G., Gasbarrini, A., & Ianiro, G. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101828 · Cited by 257
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Yang, M., Gu, Y., Li, L., Liu, T., Song, X., Sun, Y., Cao, X., Wang, B., Jiang, K., & Cao, H. (2021) · Nutrients · doi:10.3390/nu13093143 · Cited by 223
Martínez, I., Perdicaro, D. J., Brown, A. W., Hammons, S., Carden, T. J., Carr, T. P., Eskridge, K. M., & Walter, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03046-12 · Cited by 215
Race-dependent association of sulfidogenic bacteria with colorectal cancer
Yazici, C., Wolf, P. G., Kim, H., Cross, T.-W. L., Vermillion, K., Carroll, T., Augustus, G. J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313321 · Cited by 215
Impact of Diet on Human Intestinal Microbiota and Health
Salonen, A., & de Vos, W. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182554 · Cited by 220
Goldsmith, J. R., & Sartor, R. B. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0953-z · Cited by 224
Park, J. C., & Im, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0473-2 · Cited by 232
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q. ‐., & Ciaula, A. D. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 219
Patterson, E., O' Doherty, R. M., Murphy, E. F., Wall, R., O' Sullivan, O., Nilaweera, K., Fitzgerald, G. F., Cotter, P. D., Ross, R. P., & Stanton, C. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000117 · Cited by 211
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazăr, V., Diţu, L.-M., Pîrcălăbioru, G. G., Picu, A. A., Petcu, L. M., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 211
Gut microbiota, diet, and obesity-related disorders: the good, the bad, and the future challenges
Portune, K. J., Benítez‐Páez, A., Del Pulgar, E. M. G., Cerrudo, V., & Sanz, Y. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600252 · Cited by 201
Qi, Y., Jiang, C., Cheng, J., Krausz, K. W., Li, T., Ferrell, J. M., Gonzalez, F. J., & Chiang, J. Y. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.04.008 · Cited by 209
Design of synthetic human gut microbiome assembly and butyrate production
Clark, R. L., Connors, B., Stevenson, D. M., Hromada, S. E., Hamilton, J. J., Amador‐Noguez, D., & Venturelli, O. S. (2021) · Nature Communications · doi:10.1038/s41467-021-22938-y · Cited by 211
Diet and Inflammatory Bowel Disease: Review of Patient-Targeted Recommendations
Hou, J. K., Lee, D. Y., & Lewis, J. D. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.063 · Cited by 204
Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases
Huang, E. Y., Inoue, T., Leone, V. A., Dalal, S., Touw, K., Wang, Y., Musch, M. W., Theriault, B., Higuchi, K., Donovan, S., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000332 · Cited by 204
Cohen, L. J., Cho, J. H., Gevers, D., & Chu, H. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.017 · Cited by 209
Kedia, S., Virmani, S., K Vuyyuru, S., Kumar, P., Kante, B., Sahu, P., Kaushal, K., Farooqui, M., Singh, M., Verma, M., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327811 · Cited by 201
Yi, Y., Shen, L., Shi, W., Xia, F., Zhang, H., Wang, Y., Zhang, J., Wang, Y., Sun, X., Zhang, Z., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3445 · Cited by 204
Therapeutic modulation of intestinal dysbiosis
Walker, A. W., & Lawley, T. D. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.008 · Cited by 209
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps
Hale, V. L., Chen, J., Johnson, S. P., Harrington, S. C., Yab, T. C., Smyrk, T. C., Nelson, H., Boardman, L. A., Druliner, B. R., Levin, T. R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0337 · Cited by 202
Goverse, G., Molenaar, R., Macia, L., Tan, J., Erkelens, M. N., Konijn, T., Knippenberg, M., Cook, E. C. L., Hanekamp, D., Veldhoen, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600165 · Cited by 200
Kaczmarek, J. L., Musaad, S. M., & Holscher, H. D. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156380 · Cited by 200
The role of the gut microbiota in metabolic health
Janssen, A. W. F., & Kersten, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-269514 · Cited by 209
Human gut microbiota and healthy aging: Recent developments and future prospective
Kumar, M., Babaei, P., Ji, B., & Nielsen, J. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-150002 · Cited by 211
Intestinal microbiota in metabolic diseases
Clavel, T., Desmarchelier, C., Haller, D., Gérard, P., Rohn, S., Lepage, P., & Daniel, H. (2014) · Gut Microbes · doi:10.4161/gmic.29331 · Cited by 198
Effects of dietary components on intestinal permeability in health and disease
Khoshbin, K., & Camilleri, M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2020 · Cited by 206
The microbial basis of inflammatory bowel diseases
Dalal, S. R., & Chang, E. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72330 · Cited by 202
Environmental Risk Factors for Inflammatory Bowel Diseases: A Review
Ananthakrishnan, A. N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3350-9 · Cited by 196
The cross talk between microbiota and the immune system: metabolites take center stage
Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189
Microbiome, Metabolome and Inflammatory Bowel Disease
Ahmed, I., Roy, B. C., Khan, S., Septer, S. S., & Umar, S. (2016) · Microorganisms · doi:10.3390/microorganisms4020020 · Cited by 199
Peck, S. C., Denger, K., Burrichter, A., Irwin, S. M., Balskus, E. P., & Schleheck, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815661116 · Cited by 194
Obesity, fatty liver disease and intestinal microbiota
Arslan, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16452 · Cited by 200
Sawin, E. A., Wolfe, T. J. D., Aktaş, B., Stroup, B. M., Murali, S. G., Steele, J. L., & Ney, D. M. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00211.2015 · Cited by 189
Yeshi, K., Ruscher, R., Hunter, L., Daly, N. L., Loukas, A. C., & Wangchuk, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051273 · Cited by 190
Dysbiosis in intestinal inflammation: Cause or consequence
Buttó, L. F., & Haller, D. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.010 · Cited by 202
Characterization of the Fecal Bacterial Microbiota of Healthy and Diarrheic Dairy Calves
Gómez, D. E., Arroyo, L. G., Costa, M., Viel, L., & Weese, J. S. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14695 · Cited by 206
Microbiome-Mediated Effects of the Mediterranean Diet on Inflammation
Bailey, M. A., & Holscher, H. D. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy013 · Cited by 196
Steroids, stress and the gut microbiome-brain axis
Tetel, M. J., de Vries, G. J., Melcangi, R. C., Panzica, G., & O'Mahony, S. M. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12548 · Cited by 187
Diet and microbiota linked in health and disease
Requena, T., Martínez‐Cuesta, M. C., & Peláez, C. (2018) · Food & Function · doi:10.1039/c7fo01820g · Cited by 191
The germ-organ theory of non-communicable diseases
Byndloss, M. X., & Bäumler, A. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.158 · Cited by 195
Food additives, contaminants and other minor components: effects on human gut microbiota—a review
Roca-Saavedra, P., Mendez-Vilabrille, V., Miranda, J. M., Lamas, A., Nebot, C., Cardelle‐Cobas, A., Cepeda, A., & Cepeda, A. (2017) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-017-0564-2 · Cited by 204
Diet-Microbiome Interactions in Health Are Controlled by Intestinal Nitrogen Source Constraints
Holmes, A. J., Chew, Y. V., Colakoglu, F., Cliff, J. B., Klaassens, E., Read, M. N., Solon-Biet, S. M., McMahon, A. C., Cogger, V. C., Ruohonen, K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.021 · Cited by 183
Alcohol or gut microbiota: who is the guilty?
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184568 · Cited by 183
Holscher, H. D., Guetterman, H. M., Swanson, K. S., An, R., Matthan, N. R., Lichtenstein, A. H., Novotny, J. A., & Baer, D. J. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxy004 · Cited by 182
Host-microbial Cross-talk in Inflammatory Bowel Disease
Nagao‐Kitamoto, H., & Kamada, N. (2017) · Immune Network · doi:10.4110/in.2017.17.1.1 · Cited by 185
The gut microbiota as a novel regulator of cardiovascular function and disease
Battson, M. L., Lee, D. M., Weir, T. L., & Gentile, C. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.010 · Cited by 191
Martínez, I., Muller, C. E., & Walter, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069621 · Cited by 181
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
Limketkai, B. N., Iheozor‐Ejiofor, Z., Gjuladin-Hellon, T., Parian, A. M., Matarese, L. E., Bracewell, K., MacDonald, J. K., Gordon, M. A., & Mullin, G. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012839.pub2 · Cited by 182
Gilbert, M. S., Ijssennagger, N., Kies, A. K., & van Mil, S. W. C. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00319.2017 · Cited by 203
Vatanen, T., Jabbar, K. S., Ruohtula, T., Honkanen, J. K., Ávila-Pacheco, J., Siljander, H., Stražar, M., Oikarinen, S., Hyöty, H., Ilonen, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.11.023 · Cited by 182
Nguyen, L. H., Ma, W., Wang, D. D., Cao, Y., Mallick, H., Gerbaba, T. K., Lloyd‐Price, J., Abu-Ali, G., Hall, A. B., Sikavi, D. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.029 · Cited by 186
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Régnier, M., Hul, M. V., Knauf, C., & Cani, P. D. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0473 · Cited by 183
The Immunological Basis of Inflammatory Bowel Disease
Silva, F. A. R., Rodrigues, B. L., Ayrizono, M. D. L. S., & Leal, R. F. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/2097274 · Cited by 188
Zhou, F., Long, W., Hao, B., Ding, D., Ma, X., Zhao, L., & Pang, X. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0208-7 · Cited by 178
Wu, S., Stanley, D., Rodgers, N. J., Swick, R. A., & Moore, R. J. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.01.007 · Cited by 177
Postbiotics as potential new therapeutic agents for metabolic disorders management
Bourebaba, Y., Marycz, K., Mularczyk, M., & Bourebaba, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113138 · Cited by 191
Talking microbes: When gut bacteria interact with diet and host organs
Cani, P. D., & Everard, A. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500406 · Cited by 181
Rinninella, E., Mele, M. C., Merendino, N., Cintoni, M., Anselmi, G., Caporossi, A., Gasbarrini, A., & Minnella, A. M. (2018) · Nutrients · doi:10.3390/nu10111677 · Cited by 185
Parental Dietary Fat Intake Alters Offspring Microbiome and Immunity
Myles, I. A., Fontecilla, N. M., Janelsins, B., Vithayathil, P. J., Segre, J. A., & Datta, S. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301057 · Cited by 177
Understanding the role of gut microbiome in metabolic disease risk
Sanz, Y., Olivares, M., Moya-Pérez, Á., & Agostoni, C. V. (2014) · Pediatric Research · doi:10.1038/pr.2014.170 · Cited by 177
Ocvirk, S., & O’Keefe, S. J. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0219-5 · Cited by 179
The acidic pathway of bile acid synthesis: Not just an alternative pathway
Pandak, W. M., & Kakiyama, G. (2019) · Liver Research · doi:10.1016/j.livres.2019.05.001 · Cited by 181
Intersection of the Gut Microbiome and Circadian Rhythms in Metabolism
Frazier, K., & Chang, E. B. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.013 · Cited by 171
Pathogenic role of the gut microbiota in gastrointestinal diseases
Nagao‐Kitamoto, H., Kitamoto, S., Kuffa, P., & Kamada, N. (2016) · Intestinal Research · doi:10.5217/ir.2016.14.2.127 · Cited by 178
Metadata
- Authors
- Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B.
- Affiliations
- University of Chicago (US)
- Argonne National Laboratory (US)
- Corresponding author
- Chang, Eugene B.
- ORCID
- Venue
- Nature
- Published
- 2012-06-13
- Volume
- 487
- Issue
- 7405
- Pages
- 104-108
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3393783
- OpenAlex
- W2151798187
- Cited by
- 1,904
- References
- 27
- Citations by year
- 2026: 106 · 2025: 137 · 2024: 144 · 2023: 140 · 2022: 164 · 2021: 162 · 2020: 139 · 2019: 144 · 2018: 133 · 2017: 144 · 2016: 125 · 2015: 115 · 2014: 118 · 2013: 103 · 2012: 26
- FWCI
- 46.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK047722, DK-47722, R37DK047722, R01DK097268, T32DK007074, UH3DK083993, DK42086, P30DK042086)
- National Center for Complementary and Integrative Health (F31AT006073)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- taurocholate, milk fat, saturated fatty acids, Bilophila wadsworthia, colitis, IL-10-deficient mice, bile acid conjugation, taurine, gut dysbiosis, inflammatory bowel disease, Th1 response, Western diet, unsaturated fatty acids, safflower oil, gut microbiota
- MeSH terms
- Animals, Bile Acids and Salts, Colitis, Dietary Fats, Inflammation, Mice, Inbred C57BL, Milk, Molecular Sequence Data, Safflower Oil, Sulfites, Taurine, Taurocholic Acid, Inflammatory Bowel Diseases, Interleukin-10, Th1 Cells, Diet, Fat-Restricted, Bilophila, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
